Dailypharm Live Search Close

Shingrix presents a new paradigm for shingles prevention

By Eo, Yun-Ho | translator Choi HeeYoung

22.12.15 15:15:46

°¡³ª´Ù¶ó 0
GSK Korea holds a meeting to commemorate its launch

Clinical demonstration of herpes zoster prevention efficacy

 ¡ã Professor Yoon

Korea GSK's herpes zoster vaccine "Shingrix" announced its official launch. GSK held a press conference at InterContinental Seoul COEX on the 15th to commemorate the launch of Shingrix, a shingles-prevention vaccine, in Korea. At the meeting, Yoon Kyung-young, an infectious medicine professor at Korea University Anam Hospital, introduced the epidemiology of shingles, the risk of diseases and complications, and strategies to prevent shingles through unmet needs and vaccines.

Shingles occur when the varicella-zoster virus, a chickenpox-causing virus, is reactivated. Shingles are accompanied by unbearable pain, and some patients may experience neuralgia (post-shingles neuralgia) that lasts for months to ye

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)